NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 18, Pages 10632
Publisher
MDPI AG
Online
2022-09-14
DOI
10.3390/ijms231810632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nlrp3 Deficiency Alleviates Angiotensin II-Induced Cardiomyopathy by Inhibiting Mitochondrial Dysfunction
- (2021) Yu Chen et al. Oxidative Medicine and Cellular Longevity
- The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
- (2021) Vincenzo Quagliariello et al. Cardiovascular Diabetology
- NLRP3 inflammasome activation and cell death
- (2021) Yi Huang et al. Cellular & Molecular Immunology
- Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways
- (2021) Jianping Yao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis
- (2020) Kun Wang et al. CELL
- Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure
- (2020) Nikole J. Byrne et al. Circulation-Heart Failure
- Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR‐141‐mediated NLRP3 inflammasome and TGF‐β1/Smads signaling in diabetic cardiomyopathy
- (2020) Hui Che et al. FASEB JOURNAL
- Trimethylamine N‐oxide promotes apoE −/− mice atherosclerosis by inducing vascular endothelial cell pyroptosis via the SDHB/ROS pathway
- (2020) Peng Wu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- 18F-FDG PET imaging-monitored anti-inflammatory therapy for acute myocardial infarction: Exploring the role of MCC950 in murine model
- (2020) Xiang Li et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
- (2020) Yun Chen et al. Frontiers in Pharmacology
- Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells
- (2020) Rafael Corrêa et al. Frontiers in Immunology
- Diabetic cardiomyopathy: How can cardiac magnetic resonance help?
- (2020) Marijana Tadic et al. ACTA DIABETOLOGICA
- Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
- (2020) Huan Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Apigenin protects against ischemia-/hypoxia-induced myocardial injury by mediating pyroptosis and apoptosis
- (2020) Wei Li et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages
- (2020) Qin Fei et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation
- (2020) Shu Song et al. ACTA PHARMACOLOGICA SINICA
- Inhibition of Bruton's tyrosine kinase regulates macrophage NF‐κB and NLRP3 inflammasome activation in metabolic inflammation
- (2020) Gareth S.D. Purvis et al. BRITISH JOURNAL OF PHARMACOLOGY
- A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
- (2020) Alexander J M Brown et al. EUROPEAN HEART JOURNAL
- FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis
- (2020) Zhaolin Zeng et al. EXPERIMENTAL CELL RESEARCH
- Snapshot of a Deadly Embrace: The Caspase-1-GSDMD Interface
- (2020) Lieselotte Vande Walle et al. IMMUNITY
- Macrophage–NLRP3 Inflammasome Activation Exacerbates Cardiac Dysfunction after Ischemic Stroke in a Mouse Model of Diabetes
- (2020) Hong-Bin Lin et al. Neuroscience Bulletin
- A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
- (2020) José A. Nicolás-Ávila et al. CELL
- USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy
- (2020) Tao Liu et al. Cellular & Molecular Immunology
- Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial
- (2020) David C. Tong et al. CIRCULATION
- Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy
- (2020) Dan Xu et al. LIFE SCIENCES
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Succination inactivates gasdermin D and blocks pyroptosis
- (2020) Fiachra Humphries et al. SCIENCE
- NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
- (2020) Xianfei Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway
- (2020) ShiChun Shen et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF
- (2020) Yan Deng et al. CIRCULATION RESEARCH
- Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis
- (2020) Arpeeta Sharma et al. DIABETES
- MiR-21–3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor
- (2020) Peng Shi et al. EXPERIMENTAL CELL RESEARCH
- Effect of Empagliflozin and Liraglutide on the Nucleotide-Binding and Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome in a Rodent Model of Type 2 Diabetes Mellitus
- (2020) Mark Gordon et al. Canadian Journal of Diabetes
- Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes
- (2019) Zhen Qiu et al. Journal of Diabetes Research
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Extrinsic and intrinsic apoptosis activate pannexin‐1 to drive NLRP3 inflammasome assembly
- (2019) Kaiwen W Chen et al. EMBO JOURNAL
- Inflammatory caspase regulation: maintaining balance between inflammation and cell death in health and disease
- (2019) Beatriz E. Bolívar et al. FEBS Journal
- Hippo signaling controls NLRP 3 Activation and governs immunoregulation of mesenchymal stem cells in mouse liver injury
- (2019) Changyong Li et al. HEPATOLOGY
- Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization
- (2019) Zhonghua Liu et al. IMMUNITY
- Metformin in 2019
- (2019) James Flory et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation
- (2019) Xuelian Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Coriolus versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation
- (2019) Yueqiu Wang et al. PHYTOTHERAPY RESEARCH
- A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA
- (2019) Fan Yang et al. Molecular Therapy-Nucleic Acids
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Insights on Inflammasomes, Gasdermin Pores, and Pyroptosis
- (2019) Nathalia M. de Vasconcelos et al. Cold Spring Harbor Perspectives in Biology
- Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE−/− mice
- (2019) Ge Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
- (2019) Mikhail N. Kosiborod et al. CIRCULATION
- Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway
- (2019) Xuelian Li et al. LIFE SCIENCES
- The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation
- (2018) Gonzalo J. Martínez et al. ATHEROSCLEROSIS
- Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture
- (2018) Nathalia M. de Vasconcelos et al. CELL DEATH AND DIFFERENTIATION
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- LPS targets host guanylate‐binding proteins to the bacterial outer membrane for non‐canonical inflammasome activation
- (2018) José Carlos Santos et al. EMBO JOURNAL
- Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
- (2018) Hailong Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity
- (2018) Dave Boucher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of Bruton’s tyrosine kinase in B cells and malignancies
- (2018) Simar Pal Singh et al. Molecular Cancer
- Inflammasome biology, molecular pathology and therapeutic implications
- (2018) Fawaz Awad et al. PHARMACOLOGY & THERAPEUTICS
- Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
- (2018) Fan Yang et al. Cell Death & Disease
- Glycaemic variability in diabetes: clinical and therapeutic implications
- (2018) Antonio Ceriello et al. Lancet Diabetes & Endocrinology
- Role of pyroptosis in cardiovascular disease
- (2018) Zeng Zhaolin et al. CELL PROLIFERATION
- Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy
- (2018) Brahmanaidu Parim et al. HEART FAILURE REVIEWS
- OxLDL induces vascular endothelial cell pyroptosis through miR‐125a‐5p/TET2 pathway
- (2018) Zeng Zhaolin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
- (2017) Adam J Wilson et al. HEART
- The P2X7 Receptor in Infection and Inflammation
- (2017) Francesco Di Virgilio et al. IMMUNITY
- Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
- (2017) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats
- (2017) Zhen Qiu et al. Oxidative Medicine and Cellular Longevity
- NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
- (2017) Beibei Luo et al. Frontiers in Physiology
- The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
- (2016) Gerardus P.J. van Hout et al. EUROPEAN HEART JOURNAL
- Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides
- (2016) Hana M. Russo et al. JOURNAL OF IMMUNOLOGY
- Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
- (2016) Ilaria Russo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Pore-forming activity and structural autoinhibition of the gasdermin family
- (2016) Jingjin Ding et al. NATURE
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
- (2015) Justine M. Abais et al. ANTIOXIDANTS & REDOX SIGNALING
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy
- (2014) Princess Urbina et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Noncanonical Inflammasome Activation of Caspase-4/Caspase-11 Mediates Epithelial Defenses against Enteric Bacterial Pathogens
- (2014) Leigh A. Knodler et al. Cell Host & Microbe
- Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients
- (2014) David Montaigne et al. CIRCULATION
- Molecular mechanisms of diabetic cardiomyopathy
- (2014) Heiko Bugger et al. DIABETOLOGIA
- Cyclooxygenase-2 Regulates NLRP3 Inflammasome-Derived IL-1β Production
- (2014) Kuo-Feng Hua et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Myocardial fibroblast–matrix interactions and potential therapeutic targets
- (2014) Edie C. Goldsmith et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
- (2014) X Li et al. Cell Death & Disease
- Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
- (2013) Karina Huynh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
- (2013) Haitao Wen et al. IMMUNITY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Cardiac Fibroblast-Dependent Extracellular Matrix Accumulation Is Associated with Diastolic Stiffness in Type 2 Diabetes
- (2013) Kirk R. Hutchinson et al. PLoS One
- Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection
- (2013) T. Ichinohe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Negative regulation of NLRP3 inflammasome signaling
- (2013) Shuzhen Chen et al. Protein & Cell
- Caspase-11 Promotes the Fusion of Phagosomes Harboring Pathogenic Bacteria with Lysosomes by Modulating Actin Polymerization
- (2012) Anwari Akhter et al. IMMUNITY
- Inflammasomes and viruses: cellular defence versus viral offence
- (2012) A. M. Gram et al. JOURNAL OF GENERAL VIROLOGY
- Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia
- (2012) M. A. Gavrilin et al. JOURNAL OF IMMUNOLOGY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Caspase-1: is IL-1 just the tip of the ICEberg?
- (2012) A Denes et al. Cell Death & Disease
- Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action
- (2011) C Marques-da-Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Diabetic cardiomyopathy—fact or fiction?
- (2011) B. Maisch et al. HERZ
- Caspase-1-induced pyroptotic cell death
- (2011) Edward A. Miao et al. IMMUNOLOGICAL REVIEWS
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- Cellular and molecular mechanisms of vascular injury in diabetes — Part II: Cellular mechanisms and therapeutic targets
- (2011) Rosalinda Madonna et al. VASCULAR PHARMACOLOGY
- Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study
- (2010) Giovanni de Simone et al. JOURNAL OF HYPERTENSION
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels
- (2009) G. Bardini et al. DIABETES CARE
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
- (2009) Veit Hornung et al. NATURE
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Interleukin-1β and the Autoinflammatory Diseases
- (2009) Charles A. Dinarello NEW ENGLAND JOURNAL OF MEDICINE
- Lipopolysaccharide: Biosynthetic pathway and structure modification
- (2009) Xiaoyuan Wang et al. PROGRESS IN LIPID RESEARCH
- Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction
- (2008) Raymond Y. Kwong et al. CIRCULATION
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started